Recent Advances in the Molecular Imaging of Atherosclerosis

Abstract Atherosclerosis is the major underlying cause of cardiovascular diseases, the prevalence of which is continuously increasing, thus currently standing as the leading global cause of death. This pathology gradually develops over the course of 50 or more years throughout the life of an individual under the influence of a vast number of factors, both environmental and pathophysiological. This wealth of factors has elicited much research into molecular imaging, with purely diagnostic purposes or with the hope of engineering an efficient theranostic tool. To these ends, diverse nanomaterials with desirable, tunable properties have been explored by different teams, as described in this review.

• Publication year

  2020

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2020-06-30

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1055/s-0039-1701019PMID 32604420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• single‐chain antibodies

  2020cited by this paper
• Multimodal molecular imaging of atherosclerosis: Nanoparticles functionalized with scFv fragments of an anti-αIIbβ3 antibody.

  2019cited by this paper
• Association of endothelial function with thin-cap fibroatheroma as assessed by optical coherence tomography in patients with acute coronary syndromes

  2019cited by this paper
• The Relationship of NADPH Oxidases and Heme Peroxidases: Fallin' in and Out

  2019cited by this paper
• Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis

  2018cited by this paper
• Mathematical modeling of atherosclerotic plaque destabilization: Role of neovascularization and intraplaque hemorrhage.

  2018cited by this paper
• An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis

  2018cited by this paper
• PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

  2018cited by this paper
• Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity

  2018cited by this paper
• Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque

  2018cited by this paper
• Molecular Imaging of Vulnerable Atherosclerotic Plaques in Vivo with Osteopontin-Specific Upconversion Nanoprobes.

  2017cited by this paper
• Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging.

  2017cited by this paper
• Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with 18F-NaF PET-CT.

  2017cited by this paper
• The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory ‘M1’ human macrophages

  2017cited by this paper
• TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?

  2017cited by this paper
• Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library

  2017cited by this paper
• A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology

  2017cited by this paper
• Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging

  2017cited by this paper
• Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging

  2017cited by this paper
• A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting

  2017cited by this paper
• Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

  2017cited by this paper
• Molecular imaging of biological systems with a clickable dye in the broad 800- to 1,700-nm near-infrared window

  2017cited by this paper
• PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?

  2017cited by this paper
• 18-kDa translocator protein ligand 18F-FEMPA: Biodistribution and uptake into atherosclerotic plaques in mice

  2017cited by this paper
• Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease

  2017cited by this paper
• In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging.

  2017cited by this paper
• Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis

  2017cited by this paper
• Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis

  2016cited by this paper
• HDL mimetic CER-001 targets atherosclerotic plaques in patients.

  2016cited by this paper
• In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

  2016cited by this paper
• Immune cell screening of a nanoparticle library improves atherosclerosis therapy

  2016cited by this paper
• Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.

  2016cited by this paper
• Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging.

  2016cited by this paper
• Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% 64Cu-CANF-Comb

  2016cited by this paper
• Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.

  2016cited by this paper
• Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis

  2016cited by this paper
• SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.

  2016cited by this paper
• Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein

  2016cited by this paper
• Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques

  2016cited by this paper
• Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis

  2016cited by this paper
• Molecular Ultrasound Imaging of &agr;v&bgr;3-Integrin Expression in Carotid Arteries of Pigs After Vessel Injury

  2016cited by this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cited by this paper
• Labeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography.

  2016cited by this paper
• Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery.

  2016cited by this paper
• Imaging Atherosclerosis

  2016cited by this paper
• Ex vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm.

  2015cited by this paper
• Platelets in Inflammation and Atherogenesis

  2015cited by this paper
• Recent insights into the cellular biology of atherosclerosis

  2015cited by this paper
• Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI

  2015cited by this paper
• High-frequency ultrasound-guided disruption of glycoprotein VI-targeted microbubbles targets atheroprogressison in mice.

  2015cited by this paper
• The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.

  2015cited by this paper
• SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides

  2015cited by this paper
• Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus.

  2015cited by this paper
• Requiem for the 'vulnerable plaque'.

  2015cited by this paper
• Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats

  2015cited by this paper
• Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography

  2015cited by this paper
• Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE–/– Mice

  2015cited by this paper
• Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization

  2015cited by this paper
• Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo

  2015cited by this paper
• Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

  2015cited by this paper
• Variability and Uncertainty of 18F-FDG PET Imaging Protocols for Assessing Inflammation in Atherosclerosis: Suggestions for Improvement

  2015cited by this paper
• Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo.

  2015cited by this paper
• HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.

  2015cited by this paper
• Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis.

  2015cited by this paper
• Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.

  2015cited by this paper
• Multi-frequency intravascular ultrasound (IVUS) imaging

  2015cited by this paper
• 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques

  2015cited by this paper
• Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.

  2015cited by this paper
• Manganese G8 dendrimers targeted to oxidation‐specific epitopes: In vivo MR imaging of atherosclerosis

  2015cited by this paper
• Molecular Imaging of Platelet–Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis

  2015cited by this paper
• Platelets Mediate Oxidized Low-Density Lipoprotein–Induced Monocyte Extravasation and Foam Cell Formation

  2014cited by this paper
• Towards Effective and Safe Thrombolysis and Thromboprophylaxis: Preclinical Testing of a Novel Antibody-Targeted Recombinant Plasminogen Activator Directed Against Activated Platelets

  2014cited by this paper
• Prognostic Value of Nonobstructive and Obstructive Coronary Artery Disease Detected by Coronary Computed Tomography Angiography to Identify Cardiovascular Events

  2014cited by this paper
• Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

  2014cited by this paper
• Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.

  2014cited by this paper
• Platelets in inflammation and immunity

  2014cited by this paper
• A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation

  2014cited by this paper
• HDL-mediated mechanisms of protection in cardiovascular disease.

  2014cited by this paper
• PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

  2014cited by this paper
• Emerging roles for platelets as immune and inflammatory cells.

  2014cited by this paper
• Targeting P-Selectin by Gallium-68–Labeled Fucoidan Positron Emission Tomography for Noninvasive Characterization of Vulnerable Plaques: Correlation With In Vivo 17.6T MRI

  2014cited by this paper
• 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

  2014cited by this paper
• In Vivo Molecular Imaging of Thrombosis and Thrombolysis Using a Fibrin-Binding Positron Emission Tomographic Probe

  2014cited by this paper
• Fully Integrated High-Speed Intravascular Optical Coherence Tomography/Near-Infrared Fluorescence Structural/Molecular Imaging In Vivo Using a Clinically Available Near-Infrared Fluorescence–Emitting Indocyanine Green to Detect Inflamed Lipid-Rich Atheromata in Coronary-Sized Vessels

  2014cited by this paper
• Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.

  2014cited by this paper
• Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis

  2014cited by this paper
• 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis

  2014cited by this paper
• Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.

  2014cited by this paper
• Detection of activated platelets in a mouse model of carotid artery thrombosis with 18 F-labeled single-chain antibodies.

  2014cited by this paper
• Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis.

  2014cited by this paper
• Clinical utility of intravascular imaging and physiology in coronary artery disease.

  2014cited by this paper
• Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: Results from the CAMONA study

  2014cited by this paper
• Molecular MRI of Atherosclerosis

  2013cited by this paper
• Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: new possibilities for mannan-coated particles.

  2013cited by this paper
• Multimodality PET/MRI agents targeted to activated macrophages

  2013cited by this paper
• Myeloperoxidase: a front‐line defender against phagocytosed microorganisms

  2013cited by this paper
• Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques

  2013cited by this paper
• Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.

  2013cited by this paper
• Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

  2013cited by this paper
• Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.

  2013cited by this paper

• THE ROLE OF ΑIIBΒ3 RECEPTORS IN MYOCARDIAL INFARCTION: MECHANISMS AND THERAPEUTIC STRATEGIES

  2025cites this paper
• Assessment of Vitamin D3 and Selected Interleukins in Atherosclerosis Patients and Their Association with Various Biochemical Markers in Salah al-Din Governorate

  2025cites this paper
• Molecular nanoprobes for diagnosis of cardiovascular diseases

  2022cites this paper
• Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle

  2022cites this paper
• Nanomedicine in Thrombosis and Hemostasis: The Future of Nanotechnology in Thrombosis and Hemostasis Research and Clinical Applications

  2020cites this paper